Krishnamurthy Bhat

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Idiopathic Pulmonary Fibrosis

High Resolution Mass Spectrometry

Room Temperature

Top Venues

Advances in pharmacological and pharmaceutical sciences

Molecular pharmaceutics

Pharmaceutical development and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Dani Lakshman Yarlagadda, Subham Das, Sai Krishna Anand Vullendula, Suman Manandhar, Swapnil Jayant Dengale, K Sreedhara Ranganath Pai, Krishnamurthy Bhat
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement. Molecular pharmaceutics 21 (8) (2024)
Dani Lakshman Yarlagadda, Subham Das, Sai Krishna Anand Vullendula, Suman Manandhar, Swapnil Jayant Dengale, K Sreedhara Ranganath Pai, Krishnamurthy Bhat
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement. Molecular pharmaceutics 21 (8) (2024)
Dani Lakshman Yarlagadda, Subham Das, Sai Krishna Anand Vullendula, Suman Manandhar, Swapnil Jayant Dengale, K Sreedhara Ranganath Pai, Krishnamurthy Bhat
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement. Molecular pharmaceutics (2024)
Prajakta Harish Patil, Mrunal Pradeep Desai, Vullendula Sai Krishna Anand, Rajdeep Ray, Gurupur Gautham Shenoy, Swapnil Jayant Dengale, Krishnamurthy Bhat, Puralae Channabasavaiah Jagadish
A Molecular Dynamic Simulation, Structural Analysis, and Ex Vivo Insights into the P-glycoprotein-Mediated Interactions of Dietary Polyphenols with Cyclin-dependent Kinase Inhibitors: A Potential Strategy to Counteract Drug Efflux. Current medicinal chemistry (2024)
Dani Lakshman Yarlagadda, Subham Das, Sai Krishna Anand Vullendula, Suman Manandhar, Swapnil Jayant Dengale, K Sreedhara Ranganath Pai, Krishnamurthy Bhat
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement. Molecular pharmaceutics 21 (8) (2024)
Shailesh Perdalkar, Dani Lakshman Yarlagadda, Cannanore Ganesh Pai, Shiran Shetty, Krishnamurthy Bhat
Liquid chromatographic methods in the determination of inosine monophosphate dehydrogenase enzyme activity: a review. Bioanalysis 14 (22) (2023)
Shailesh Perdalkar, Dani Lakshman Yarlagadda, Cannanore Ganesh Pai, Shiran Shetty, Krishnamurthy Bhat
Liquid chromatographic methods in the determination of inosine monophosphate dehydrogenase enzyme activity: a review. Bioanalysis 14 (22) (2023)
Muralidhar Pisay, Dani Lakshman Yarlagadda, Vullendula Sai Krishna Anand, Krishnamurthy Bhat, Koteshwara Kunnatur Balasundara, Srinivas Mutalik
Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution. Pharmaceutical development and technology 28 (2) (2023)
Dani Lakshman Yarlagadda, Akshatha M Nayak, Bheemisetty Brahmam, Krishnamurthy Bhat
Exploring the Solubility and Bioavailability of Sodium Salt and Its Free Acid Solid Dispersions of Dolutegravir. Advances in pharmacological and pharmaceutical sciences 2023 (2023)
Mrunal Pradeep Desai, Prajakta Harish Patil, Vullendula Sai Krishna Anand, Sumit Raosaheb Birangal, Gurupur Gautham Shenoy, Mahadev Rao, Swapnil Jayant Dengale, Krishnamurthy Bhat, Puralae Channabasavaiah Jagadish
Molecular Insights into the Mechanism of Modulatory Effects of Proton Pump Inhibitors on P-glycoprotein Mediated Drug Transport of Palbociclib and Ribociclib. Current drug metabolism (2023)
Dani Lakshman Yarlagadda, Akshatha M Nayak, Bheemisetty Brahmam, Krishnamurthy Bhat
Exploring the Solubility and Bioavailability of Sodium Salt and Its Free Acid Solid Dispersions of Dolutegravir. Advances in pharmacological and pharmaceutical sciences 2023 (2023)
Muralidhar Pisay, Dani Lakshman Yarlagadda, Vullendula Sai Krishna Anand, Krishnamurthy Bhat, Koteshwara Kunnatur Balasundara, Srinivas Mutalik
Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution. Pharmaceutical development and technology 28 (2) (2023)
Muralidhar Pisay, Dani Lakshman Yarlagadda, Vullendula Sai Krishna Anand, Krishnamurthy Bhat, Koteshwara Kunnatur Balasundara, Srinivas Mutalik
Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution. Pharmaceutical development and technology 28 (2) (2023)
Muralidhar Pisay, Dani Lakshman Yarlagadda, Vullendula Sai Krishna Anand, Krishnamurthy Bhat, Koteshwara Kunnatur Balasundara, Srinivas Mutalik
Effervescence-induced amorphous solid dispersions with improved drug solubility and dissolution. Pharmaceutical development and technology (2023)
Dani Lakshman Yarlagadda, Akshatha M Nayak, Bheemisetty Brahmam, Krishnamurthy Bhat
Exploring the Solubility and Bioavailability of Sodium Salt and Its Free Acid Solid Dispersions of Dolutegravir. Advances in pharmacological and pharmaceutical sciences 2023 (2023)
Shailesh Perdalkar, Dani Lakshman Yarlagadda, Cannanore Ganesh Pai, Shiran Shetty, Krishnamurthy Bhat
Liquid chromatographic methods in the determination of inosine monophosphate dehydrogenase enzyme activity: a review. Bioanalysis (2023)
Dani Lakshman Yarlagadda, Akshatha M Nayak, Bheemisetty Brahmam, Krishnamurthy Bhat
Exploring the Solubility and Bioavailability of Sodium Salt and Its Free Acid Solid Dispersions of Dolutegravir. Advances in pharmacological and pharmaceutical sciences 2023 (2023)
Navya Sree K S, Swapnil Jayant Dengale, Srinivas Mutalik, Krishnamurthy Bhat
Raloxifene HCl - quercetin co-amorphous system: preparation, characterization, and investigation of its behavior in phosphate buffer. Drug development and industrial pharmacy 48 (6) (2022)